相关实验视频
Updated: Jul 5, 2025
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.3K
在中度至重度过敏喘患者的不同剂量方案中,奥马利祖马布的有效性
Nicole M Chase1, Monica Littlejohn2, Cecile T J Holweg3
1University of Minnesota, Minneapolis, MN, USA.
Respiratory medicine
|January 22, 2024
概括
奥马利祖马布改善了中度至重度过敏性喘患者的喘控制和生活质量,无论他们的基线免疫球蛋白E (IgE) 水平和体重是否符合推剂量表.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 临床试验 临床试验
背景情况:
- 奥马利祖马布是一种适度至重度持续性过敏喘的生物治疗方法.
- 剂量是根据患者体重和血清免疫球蛋白E (IgE) 水平的表格来指导.
- 普洛斯佩罗试验评估了奥马利祖马布在过敏性喘患者中的有效性.
研究的目的:
- 评估接受奥马利祖马布的过敏性喘患者的喘结果和生活质量.
- 根据他们的基线IgE和体重相对于批准的剂量表来分层患者.
- 为了评估奥马利祖马布在不同剂量层中的疗效.
主要方法:
- 从PROSPERO试验 (ClinicalTrials.gov:NCT01922037) 的数据分析.
- 患者被分为三个组:内部剂量表 (n=506),数据不足以推剂量 (n=72) 和外部剂量表 (n=209).
- 结果包括喘控制指标和生命质量评估在开始使用omalizumab后.
主要成果:
- 在所有分析的患者群体中,omalizumab治疗导致了喘控制和生活质量的改善.
- 接受在推剂量参数范围内治疗的患者表现出积极的结果.
- 治疗在推剂量参数之外的患者也表现出显著的改善.
结论:
- 奥马利祖马布治疗在改善中度至重度过敏性喘患者的广泛范围内的喘控制和生活质量方面表现出有效性.
- 这项研究表明,即使在患者的基线特征超出标准剂量建议之外,奥马利祖马布也可能有益.
- 进一步的研究可能会探索目前指南之外的患者的最佳剂量策略.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
01:19Antiasthma Drugs: Leukotriene Modifiers
302
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
302
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
252
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
252
01:17Drugs Used in Lower Respiratory Disorders: Overview
445
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
445
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267